Physician profile
Makram Ebeid
NPI 1386672970
$285,320.38
in general payments reported to CMS, 2019-2025
14 companies · $5,185 in 2025
The $5,185 reported for 2025 was more than what 92% of Pediatric Cardiology providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $142K · 2020: $59K · 2021: $43K · 2022: $1,381 · 2023: $29K · 2024: $5,942 · 2025: $5,185.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $13K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $13K · Travel and Lodging: $6,147 · Food and Beverage: $4,546 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $3,900.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $12,900.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $12,669.23 |
| Travel and Lodging | $6,147.29 |
| Food and Beverage | $4,545.81 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $3,900.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $221,370.26 | 2019-2025 | Amplatzer Piccolo, Amplatzer Talisman, Mitraclip |
| Edwards Lifesciences Corporation | $53,309.70 | 2019-2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), The Edwards Sapien 3 Valve With Alterra Adaptive Prestent System |
| Numed For Children, LLC | $4,301.79 | 2019-2025 | |
| Medtronic, INC. | $3,710.45 | 2021-2025 | Harmony, Linq II |
| Medtronic Vascular, INC. | $1,510.23 | 2019 | |
| Biotronik INC. | $360.22 | 2019-2020 | |
| W. L. Gore & Associates, INC. | $311.03 | 2019-2022 | |
| Penumbra, INC. | $155.05 | 2022-2023 | Ruby Coil |
| Janssen Pharmaceuticals, INC | $109.65 | 2024 | Xarelto |
| B. Braun Interventional Systems INC. | $75.56 | 2019-2023 | No Marketed Product Name |
| Canon Medical Systems USA, INC. | $43.40 | 2025 | Diagnostic Ultrasound System |
| Cardiva Medical, INC. | $23.78 | 2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Cook Medical LLC | $20.21 | 2019 | |
| Boston Scientific Corporation | $19.05 | 2025 | Express Ld Iliac / Biliary |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Makram Ebeid listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.